Watchlist Price Alert

Avadel Pharmaceuticals (AVDL)

NASDAQ: AVDL · Real-Time Price · USD

9.53

0.03 (0.32%)

At close: Jun 17, 2025, 1:57 PM

Avadel Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	51.37M	31.17M	73.98M	50.71M	71.72M	9.77M	9.32M	16.56M	39.22M
Short-Term Investments	22.41M	73.94M	22.52M	106.51M	149.68M	54.38M	90.59M	77.51M	114.98M
Long-Term Investments	n/a	n/a	1.23M	-22.9M	-14.81M	-23.11M	8.75M	1.4M	1.77M
Other Long-Term Assets	11.04M	579K	-60.02M	33.78M	24.94M	39.27M	5.75M	9.1M	7.53M
Receivables	34.1M	13.43M	n/a	n/a	3.33M	8.28M	13.91M	16.51M	17.84M
Inventory	20.3M	10.38M	n/a	n/a	n/a	3.57M	4.77M	6.16M	3.26M
Other Current Assets	882K	913K	2.82M	32.09M	2.25M	4.25M	4.11M	128K	2.45M
Total Current Assets	134.21M	134.2M	100.84M	192.49M	263.45M	82.38M	124.85M	123.95M	181.19M
Property-Plant & Equipment	2.15M	13.08M	2.55M	2.94M	2.96M	4.16M	7.8M	3M	3.32M
Goodwill & Intangibles	16.84M	16.84M	16.84M	16.84M	16.84M	19.3M	20.12M	110.78M	41.33M
Total Long-Term Assets	30.03M	30.5M	31.94M	54.77M	48.18M	69.06M	65.45M	128.15M	64.3M
Total Assets	164.24M	164.7M	132.78M	247.26M	311.64M	151.44M	190.3M	252.11M	245.48M
Account Payables	7.33M	11.43M	7.89M	7.68M	2.93M	6.1M	3.5M	7.48M	7.11M
Deferred Revenue	n/a	n/a	n/a	7.15M	6.5M	25.36M	114K	2.01M	2.22M
Short-Term Debt	582K	934K	38.63M	900K	474K	645K	106K	111K	268K
Other Current Liabilities	32.52M	11.59M	6.7M	2.62M	3.73M	4.48M	29.74M	72.17M	48.33M
Total Current Liabilities	48.83M	36.85M	55.79M	21M	15.11M	35.98M	38.38M	86.18M	62.42M
Long-Term Debt	n/a	32.76M	91.61M	142.4M	128.21M	121.69M	115.73M	156K	547K
Other Long-Term Liabilities	40.43M	5.65M	5.74M	3.92M	4.21M	20.65M	33.4M	81M	140.44M
Total Long-Term Liabilities	41.55M	40.1M	98.14M	148.02M	134.26M	144.65M	149.14M	81.37M	140.99M
Total Liabilities	90.39M	76.96M	153.93M	169.02M	149.37M	180.63M	187.52M	167.54M	203.41M
Total Debt	1.7M	35.38M	131.02M	145M	130.52M	124.65M	115.84M	267K	815K
Common Stock	965K	898K	628K	586K	583K	429K	427K	414K	414K
Retained Earnings	-794.33M	-745.5M	-585.22M	-447.76M	-384.19M	-391.21M	-357.99M	-263.7M	-319.8M
Comprehensive Income	-24.58M	-23.17M	-26.34M	-23.94M	-21.05M	-22.81M	-23.42M	-23.27M	-23.57M
Shareholders Equity	73.85M	87.74M	-21.14M	78.24M	162.27M	-29.2M	2.78M	84.56M	42.07M
Total Investments	22.41M	73.94M	22.52M	106.51M	149.68M	54.38M	90.59M	77.51M	114.98M